FREMANEZUMAB VFRM

N/A

Manufactured by Teva Pharmaceuticals USA, Inc.

22,887 FDA adverse event reports analyzed

Last updated: 2026-04-14

About FREMANEZUMAB VFRM

FREMANEZUMAB VFRM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Teva Pharmaceuticals USA, Inc.. The most commonly reported adverse reactions for FREMANEZUMAB VFRM include ACCIDENTAL EXPOSURE TO PRODUCT, INJECTION SITE PAIN, MIGRAINE, DRUG INEFFECTIVE, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FREMANEZUMAB VFRM.

Top Adverse Reactions

ACCIDENTAL EXPOSURE TO PRODUCT1,407 reports
INJECTION SITE PAIN1,253 reports
MIGRAINE949 reports
DRUG INEFFECTIVE868 reports
HEADACHE701 reports
INJECTION SITE ERYTHEMA621 reports
DEVICE LEAKAGE554 reports
INJECTION SITE PRURITUS477 reports
DEVICE MALFUNCTION457 reports
FATIGUE452 reports
NAUSEA452 reports
INJECTION SITE SWELLING422 reports
DRUG DOSE OMISSION BY DEVICE398 reports
INCORRECT DOSE ADMINISTERED BY DEVICE380 reports
DIZZINESS360 reports
PRODUCT DOSE OMISSION ISSUE357 reports
PRURITUS337 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION306 reports
RASH295 reports
PAIN292 reports
ALOPECIA289 reports
INJECTION SITE REACTION289 reports
CONSTIPATION288 reports
DEVICE ISSUE288 reports
ARTHRALGIA273 reports
NEEDLE ISSUE271 reports
INCORRECT DOSE ADMINISTERED264 reports
INJECTION SITE RASH264 reports
ANXIETY256 reports
MALAISE236 reports
DEVICE DELIVERY SYSTEM ISSUE231 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS229 reports
DYSPNOEA227 reports
PRODUCT USE ISSUE223 reports
INJECTION SITE MASS217 reports
FEELING ABNORMAL215 reports
URTICARIA211 reports
WEIGHT INCREASED202 reports
DEVICE DIFFICULT TO USE195 reports
HYPERSENSITIVITY193 reports
INJECTION SITE HAEMORRHAGE193 reports
INJECTION SITE BRUISING189 reports
INSOMNIA182 reports
WRONG TECHNIQUE IN DEVICE USAGE PROCESS182 reports
VOMITING179 reports
INJECTION SITE URTICARIA169 reports
INJECTION SITE EXTRAVASATION166 reports
PALPITATIONS162 reports
ERYTHEMA146 reports
OFF LABEL USE146 reports
COVID 19145 reports
DIARRHOEA145 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE142 reports
DEPRESSION140 reports
PRODUCT STORAGE ERROR140 reports
CHEST PAIN134 reports
PAIN IN EXTREMITY129 reports
DEVICE DEFECTIVE125 reports
INJECTION SITE WARMTH125 reports
ASTHENIA122 reports
THERAPEUTIC RESPONSE SHORTENED121 reports
INJECTION SITE DISCHARGE120 reports
PARAESTHESIA120 reports
MYALGIA116 reports
ILLNESS109 reports
DRUG HYPERSENSITIVITY108 reports
FALL106 reports
HYPOAESTHESIA105 reports
HYPERTENSION102 reports
ADVERSE EVENT101 reports
ABDOMINAL PAIN UPPER98 reports
CHEST DISCOMFORT98 reports
PRODUCT USE IN UNAPPROVED INDICATION96 reports
BACK PAIN95 reports
PERIPHERAL SWELLING95 reports
TREMOR94 reports
SYNCOPE93 reports
MUSCLE SPASMS91 reports
VISUAL IMPAIRMENT88 reports
VERTIGO87 reports
LOSS OF CONSCIOUSNESS86 reports
SEIZURE86 reports
SWELLING85 reports
PYREXIA84 reports
ABDOMINAL PAIN83 reports
SOMNOLENCE83 reports
NECK PAIN82 reports
VISION BLURRED82 reports
ADVERSE DRUG REACTION81 reports
CEREBROVASCULAR ACCIDENT80 reports
WEIGHT DECREASED79 reports
COUGH78 reports
DEATH77 reports
THERAPEUTIC PRODUCT EFFECT DECREASED76 reports
ABDOMINAL DISTENSION75 reports
BLOOD PRESSURE INCREASED75 reports
HEART RATE INCREASED75 reports
ABDOMINAL DISCOMFORT73 reports
INJECTION SITE INDURATION72 reports
SWELLING FACE72 reports

Report Outcomes

Out of 10,665 classified reports for FREMANEZUMAB VFRM:

Serious 31.6%Non-Serious 68.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female8,440 (88.5%)
Male1,067 (11.2%)
Unknown30 (0.3%)

Reports by Age

Age 52179 reports
Age 44167 reports
Age 51162 reports
Age 50149 reports
Age 53146 reports
Age 42145 reports
Age 59143 reports
Age 43140 reports
Age 41136 reports
Age 45136 reports
Age 49136 reports
Age 40135 reports
Age 48135 reports
Age 57134 reports
Age 46131 reports
Age 38129 reports
Age 60124 reports
Age 62124 reports
Age 39122 reports
Age 47122 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with FREMANEZUMAB VFRM?

This profile reflects 22,887 FDA FAERS reports that mention FREMANEZUMAB VFRM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for FREMANEZUMAB VFRM?

Frequently reported terms in FAERS include ACCIDENTAL EXPOSURE TO PRODUCT, INJECTION SITE PAIN, MIGRAINE, DRUG INEFFECTIVE, HEADACHE, INJECTION SITE ERYTHEMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures FREMANEZUMAB VFRM?

Labeling and FAERS entries often list Teva Pharmaceuticals USA, Inc. in connection with FREMANEZUMAB VFRM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.